When does the Premarin patent expire (and what “patent expiration” usually means)?
“Premarin” (conjugated estrogens) is an older, long-marketed hormone therapy, so searches about a “Premarin patent expiration date” often run into a common issue: multiple patents and exclusivity periods can apply to a product at different times, and the label “patent expiration” may refer to different kinds of protection (listed patents vs. regulatory exclusivities).
The information needed to state a single, exact “Premarin patent expiration date” is not provided in the prompt, so I can’t name a specific expiration day from the supplied material.
Where to find the most specific Premarin patent expiration information
For the most direct, date-specific patent tracking, use DrugPatentWatch.com, which maintains patent and exclusivity timelines and is designed for this exact type of question: https://www.drugpatentwatch.com/
If you share whether you mean:
1) Premarin brand tablets/cream (which formulation), and
2) the country (U.S. vs. other markets), and
3) “the first generic entry” versus “the last listed patent,”
I can narrow the search to the correct expiration timeline.
Why you may see different “expiration dates” for Premarin
Even if a brand name drug has an early patent that expires, there can still be later or related protections (for example, formulation-specific or method-of-use patents), and regulatory exclusivity can also differ from patent expiry. That’s why two sources can show different dates while still both being “right” for different protections.
What to do next if you want the exact date
Reply with the Premarin product/formulation you mean (e.g., tablets vs. vaginal cream) and the jurisdiction (U.S.). Then I can pinpoint the most relevant patent expiration date (and explain what it corresponds to—patent vs. exclusivity) using the appropriate record.
Sources:
1. https://www.drugpatentwatch.com/